Regenerex Pharma, Inc. (RGPX) — 10-K Filings
All 10-K filings from Regenerex Pharma, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Regenerex Pharma Narrows Loss to $1,000 Amidst Zero Revenue
— Jun 30, 2025 Risk: high
REGENEREX PHARMA, INC. reported no revenue for the fiscal year ended March 31, 2025, consistent with the prior year. The company incurred a net loss of $1,000 f -
Regenerex Pharma Files 2024 Annual Report
— Jun 24, 2024 Risk: low
Regenerex Pharma, Inc. filed its annual report for the fiscal year ended March 31, 2024. The company, formerly known as Peptide Technologies, Inc. and Eternelle
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX